Last reviewed · How we verify
Dexmedetomidine 5 mcg
Dexmedetomidine 5 mcg is a Small molecule drug developed by Bahria International Hospital. It is currently FDA-approved. Also known as: Dexmedetomidine 5mcg.
Dexmedetomidine 5 mcg, marketed by Bahria International Hospital, holds a position in the sedative and analgesic market with a key composition patent expiring in 2028. The drug's key strength lies in its established market presence and the protection offered by its patent. The primary risk is the potential increase in competition post-patent expiry in 2028.
At a glance
| Generic name | Dexmedetomidine 5 mcg |
|---|---|
| Also known as | Dexmedetomidine 5mcg |
| Sponsor | Bahria International Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Continuous Epidural With Dexmedetomidine Adjuvant in Gynecologic Laparotomy (PHASE4)
- Dexmedetomidine Use in SZMN Blocks for Pediatric T&A Pain Control (NA)
- Comparing Doses of Intrathecal Dexmedetomidine (PHASE4)
- Oral Dexmedetomidine in Pediatric MRI (PHASE1)
- Evaluation of the Effect of Dexmedetomidine on Phenylephrine Response During Refractory Septic Shock (PHASE3)
- Propofol-Only Versus Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging (PHASE4)
- Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle (EARLY_PHASE1)
- Intrathecal Dexmedetomidine vs Epinephrine (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexmedetomidine 5 mcg CI brief — competitive landscape report
- Dexmedetomidine 5 mcg updates RSS · CI watch RSS
- Bahria International Hospital portfolio CI
Frequently asked questions about Dexmedetomidine 5 mcg
What is Dexmedetomidine 5 mcg?
Who makes Dexmedetomidine 5 mcg?
Is Dexmedetomidine 5 mcg also known as anything else?
What development phase is Dexmedetomidine 5 mcg in?
Related
- Manufacturer: Bahria International Hospital — full pipeline
- Also known as: Dexmedetomidine 5mcg
- Compare: Dexmedetomidine 5 mcg vs similar drugs
- Pricing: Dexmedetomidine 5 mcg cost, discount & access